| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.104.524801 |
| P698 | PubMed publication ID | 16159802 |
| P50 | author | Rabea Hinkel | Q41532545 |
| Franz-Josef Gildehaus | Q47460839 | ||
| Christian Kupatt | Q88403558 | ||
| Peter Boekstegers | Q114337163 | ||
| Jan Horstkotte | Q114399865 | ||
| P2093 | author name string | Marie-Luise von Brühl | |
| Hildegard Büning | |||
| Antonis K Hatzopoulos | |||
| Susanne Müller | |||
| Tilman Pohl | |||
| Heike Beck | |||
| Mathias Lamparter | |||
| Sebastian Delker | |||
| P433 | issue | 9 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| reperfusion injury | Q1413991 | ||
| P304 | page(s) | I117-22 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase | |
| P478 | volume | 112 |
| Q42593149 | Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety |
| Q36820225 | Biologic properties of endothelial progenitor cells and their potential for cell therapy |
| Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
| Q36957758 | Cardiac side effects of anticancer treatments: new mechanistic insights |
| Q42775592 | Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition |
| Q27025843 | Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction? |
| Q39359620 | Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: involvement of AKT activation |
| Q34784406 | Neuregulin-1β regulation of embryonic endothelial progenitor cell survival |
| Q37767614 | Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. |
| Q36855438 | Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends |
| Q37053167 | Progenitor cells and vascular disease |
| Q35459718 | Rafs constitute a nodal point in the regulation of embryonic endothelial progenitor cell growth and differentiation |
| Q34544884 | Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity |
| Q26739985 | Recent Stem Cell Advances: Cord Blood and Induced Pluripotent Stem Cell for Cardiac Regeneration- a Review |
| Q37821376 | Regenerative therapies in electrophysiology and pacing: introducing the next steps |
| Q34757960 | Rescuing the failing heart by targeted gene transfer |
| Q47697828 | Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data |
| Q35125820 | Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. |
| Q36836349 | Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology |
| Q26866170 | Stem cell therapy for chronic heart failure: an updated appraisal |
| Q38114860 | Stem cell therapy for heart disease |
| Q33348580 | Stem cell therapy: pieces of the puzzle |
| Q37168629 | Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection |
| Q41892971 | Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia |
Search more.